BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30165334)

  • 1. Falsification of biotechnology drugs: current dangers and/or future disasters?
    Janvier S; De Spiegeleer B; Vanhee C; Deconinck E
    J Pharm Biomed Anal; 2018 Nov; 161():175-191. PubMed ID: 30165334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market.
    Janvier S; Cheyns K; Canfyn M; Goscinny S; De Spiegeleer B; Vanhee C; Deconinck E
    Talanta; 2018 Oct; 188():795-807. PubMed ID: 30029448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview on performance and image enhancing drugs (PIEDs) confiscated in Italy in the period 2017-2019.
    Odoardi S; Mestria S; Biosa G; Valentini V; Federici S; Strano Rossi S
    Clin Toxicol (Phila); 2021 Jan; 59(1):47-52. PubMed ID: 32475176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V; Soloviov A; Olefir A
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current cases of falsified medicinal products within the competence of the Federal Institute for Drugs and Medical Devices (BfArM) : Case studies and extent].
    Wittstock M; Paeschke N
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1196-1202. PubMed ID: 28980029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benchtop low-field
    Assemat G; Balayssac S; Gerdova A; Gilard V; Caillet C; Williamson D; Malet-Martino M
    Talanta; 2019 May; 196():163-173. PubMed ID: 30683346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting falsified medicines: The analytical approach.
    Rebiere H; Guinot P; Chauvey D; Brenier C
    J Pharm Biomed Anal; 2017 Aug; 142():286-306. PubMed ID: 28531832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plague of unexpected drug recalls and the pandemic of falsified medications in cardiovascular medicine as a threat to patient safety and global public health: A brief review.
    Świeczkowski D; Zdanowski S; Merks P; Szarpak Ł; Vaillancourt R; Jaguszewski MJ
    Cardiol J; 2022; 29(1):133-139. PubMed ID: 33346374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe.
    Venhuis BJ; Keizers PH; Klausmann R; Hegger I
    Drug Test Anal; 2016; 8(3-4):398-401. PubMed ID: 26456392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of illegal peptide biopharmaceuticals frequently encountered by controlling agencies.
    Vanhee C; Janvier S; Desmedt B; Moens G; Deconinck E; De Beer JO; Courselle P
    Talanta; 2015 Sep; 142():1-10. PubMed ID: 26003685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inorganic analysis of falsified medical products using X-ray fluorescence spectroscopy and chemometrics.
    Rebiere H; Kermaïdic A; Ghyselinck C; Brenier C
    Talanta; 2019 Apr; 195():490-496. PubMed ID: 30625574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current challenges in the detection and analysis of falsified medicines.
    Bakker-'t Hart IME; Ohana D; Venhuis BJ
    J Pharm Biomed Anal; 2021 Apr; 197():113948. PubMed ID: 33582458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The health consequences of falsified medicines- A study of the published literature.
    Rahman MS; Yoshida N; Tsuboi H; Tomizu N; Endo J; Miyu O; Akimoto Y; Kimura K
    Trop Med Int Health; 2018 Dec; 23(12):1294-1303. PubMed ID: 30291683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Falsified vardenafil tablets available online.
    Zhu S; Yoshida N; Kimura K; Matsushita R; Tsuboi H
    J Pharm Biomed Anal; 2020 Jan; 177():112872. PubMed ID: 31525574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders.
    Fabresse N; Gheddar L; Kintz P; Knapp A; Larabi IA; Alvarez JC
    Forensic Sci Int; 2021 May; 322():110771. PubMed ID: 33838562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Falsified medicines in parallel trade].
    Muckenfuß H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1208-1213. PubMed ID: 28905079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sounding out falsified medicines from genuine medicines using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS).
    Alfarsi A; Caillet C; Fawbert G; Lawrence S; Krüse J; McSweeney S; O'Mahony M; Dondorp A; Newton PN; Fitzpatrick D
    Sci Rep; 2021 Jun; 11(1):12643. PubMed ID: 34135361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.